Investigation of intramolecular dynamics and conformations of α-, β- and γ-synuclein

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Ducas, Vanessa C ^a   Rhoades, Elizabeth ^a,b  

^a YALE UNIVERSITY   (United States)

^b Yale University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; SOLUTION AND SOLUBILITY;

ARTICLE; DIFFUSION COEFFICIENT; FLUORESCENCE CORRELATION SPECTROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; MOLECULAR DYNAMICS; PH; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; AMINO ACID SEQUENCE; CHEMISTRY; DIFFUSION; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SOLUTION AND SOLUBILITY;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; BETA-SYNUCLEIN; DIFFUSION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GAMMA-SYNUCLEIN; HYDROGEN-ION CONCENTRATION; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SOLUTIONS;

EID: 84900308987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086983     Document Type: Article

References (74)

1. Lavedan C (1998) The synuclein family. Genome Res 8: 871-880.
2. Chandra S, Fornai F, Kwon H-B, Yazdani U, Atasoy D, et al. (2004) Double-knockout mice for α- and β-synucleins: Effect on synaptic functions. Proc Natl Acad Sci 101: 14966-14971. (Pubitemid 39410782)
3. Bartels T, Choi JG, Selkoe DJ (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477: 107-110.
4. Wang W, Perovic I, Chittuluru J, Kaganovich A, Nguyen LTT, et al. (2011) A soluble α-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci 108: 17797-17802.
5. Trexler AJ, Rhoades E (2012) N-terminal acetylation is critical for forming α-helical oligomer of α-synuclein. Protein Sci 21: 601-605.
6. Bertoncini CW, Rasia RM, Lamberto GR, Binolfi A, Zweckstetter M, et al. (2007) Structural characterization of the intrinsically unfolded protein β-synuclein, a natural negative regulator of α-synuclein aggregation. J Mol Biol 372: 708-722. (Pubitemid 47313489)
7. Rivers RC, Kumita JR, Tartaglia GG, Dedmon MM, Pawar A, et al. (2008) Molecular determinants of the aggregation behavior of α- and β-synuclein. Protein Sci 17: 887-898. (Pubitemid 351629583)
8. Segrest JP, Jones MK, De Loof H, Brouillette CG, Venkatachalapathi YV, et al. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 33: 141-166.
9. Drin G, Antonny B (2010) Amphipathic helices and membrane curvature. FEBS Lett 584: 1840-1847.
10. Sung Y-H, Eliezer D (2006) Secondary structure and dynamics of micelle bound β- and γ-synuclein. Prot Sci 15: 1162-1174.
11. Uversky VN, Li J, Souillac P, Millett IS, Doniach S, et al. (2002) Biophysical properties of the synucleins and their propensities to fibrillate. J Biol Chem 277: 11970-11978.
12. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047. (Pubitemid 27443610)
13. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, et al. (1997) α-Synuclein in Lewy bodies. Nature 388: 839-840.
14. George JM (2002) The synucleins. Genome Biol 3: REVIEWS3002.
15. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
16. Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, et al. (2004) The new mutation, E46K, of α-synuclein causes parkinson and Lewy body dementia. Ann Neurol 55: 164-173. (Pubitemid 38166992)
17. Bradbury J (2003) α-synuclein gene triplication discovered in Parkinson's disease. Lancet Neurol 2: 715.
18. Kara E, Lewis PA, Ling H, Proukakis C, Houlden H, et al. (2013) α-Synuclein mutations cluster around a putative protein loop. Neurosci Lett 546: 67-70.
19. Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2: 492-501.
20. Ohtake H, Limprasert P, Fan Y, Onodera O, Kakita A, et al. (2004) β-Synuclein gene alterations in dementia with Lewy bodies. Neurology 63: 805-811. (Pubitemid 39297638)
21. Ducas VC, Rhoades E (2012) Quantifying interactions of β-synuclein and γ-synuclein with model membranes. J Mol Biol 423: 528-539.
22. Fujita M, Sekigawa A, Sekiyama K, Sugama S, Hashimoto M (2009) Neurotoxic conversion of β-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies? J Neurol 256: 286-292.
23. Fujita M, Sugama S, Sekiyama K, Sekigawa A, Tsukui T, et al. (2010) A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain. Nat Commun 1: 110.
24. Wei J, Fujita M, Nakai M, Waragai M, Watabe K, et al. (2007) Enhanced lysosomal pathology caused by β-synuclein mutants linked to dementia with Lewy bodies. J Biol Chem 282: 28904-28914. (Pubitemid 47606052)
25. Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E (2001) β- Synuclein inhibits α-synuclein aggregation: A possible role as an anti-Parkinsonian factor. Neuron 32: 213-223. (Pubitemid 33030190)
26. Pan Z-Z, Bruening W, Giasson BI, Lee VMY, Godwin AK (2002) γ-Synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. J Biol Chem 277: 35050-35060.
27. Pan Z-Z, Godwin AK (2006) Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility. Int J Oncol 29: 1201-1205.
28. Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OMA (2007) γ-Synuclein and the progression of cancer. FASEB J 21: 3419-3430.
29. Singh VK, Zhou Y, Marsh JA, Uversky VN, Forman-Kay JD, et al. (2007) Synuclein-γ targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res 67: 626-633. (Pubitemid 46192201)
30. Manivel P, Muthukumaran J, Kannan M, Krishna R (2011) Insight into residues involved in the structure and function of the breast cancer associated protein human gamma- synuclein. Journal of Molecular Modeling 17: 251-263.
31. Surguchov A (2013) Synucleins: Are they two-edged swords? J Neurosci Res 91: 161-166.
32. Surguchov A, Palazzo RE, Surgucheva I (2001) Gamma-synuclein: Subcellular localization in neuronal and non-neuronal cells and effect on signal transduction. Cell Motil Cytoskeleton 49: 218-228. (Pubitemid 32802695)
33. Surgucheva I, Park B-C, Yue B, Tomarev S, Surguchov A (2005) Interaction of myocilin with γ-synuclein affects its secretion and aggregation. Cell Mol Neurobiol 25: 1009-1033. (Pubitemid 43154824)
34. Surguchov A (2008) Molecular and cellular biology of synucleins. Int Rev Cell Mol Biol 270: 225-317.
35. Dedmon MM, Lindorff-Larsen K, Christodoulou J, Vendruscolo M, Dobson CM (2004) Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc 127: 476-477. (Pubitemid 40174345)
36. Marsh JA, Singh VK, Jia Z, Forman-Kay JD (2006) Sensitivity of secondary structure propensities to sequence differences between α- and γ-synuclein: Implications for fibrillation. Protein Sci 15: 2795-2804. (Pubitemid 44833760)
37. von Bergen M, Barghorn S, Biernat J, Mandelkow E-M, Mandelkow E (2005) Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim Biophys Acta- Mol Basis Dis 1739: 158-166.
38. Gregersen N, Bolund L, Bross P (2005) Protein misfolding, aggregation, and degradation in disease. Molec Biotech 31: 141-150. (Pubitemid 41306583)
39. Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, et al. (2008) Conformational equilibria in monomeric α-synuclein at the single-molecule level. PLoS Biol 6: e6.
40. Biere AL, Wood SJ, Wypych J, Steavenson S, Jiang Y, et al. (2000) Parkinson's disease-associated α-synuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs. J Biol Chem 275: 34574-34579.
41. Eliezer D, Kutluay E, Bussell Jr R, Browne G (2001) Conformational properties of α-synuclein in its free and lipid-associated states. J Mol Biol 307: 1061-1073. (Pubitemid 33029953)
42. Middleton ER, Rhoades E (2010) Effects of curvature and composition on α-synuclein binding to lipid vesicles. Biophys J 99: 2279-2288.
43. Lavedan C, Leroy E, Dehejia A, Buchholtz S, Dutra A, et al. (1998) Identification, localization and characterization of the human γ-synuclein gene. Hum Genet 103: 106-112. (Pubitemid 28398395)
44. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, et al. (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7: 1-6.
45. Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ (2009) Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25: 1189-1191.
46. Schwille P, Haustein E (2009) Fluorescence correlation spectroscopy - An introduction to its concepts and applications. Spectroscopy 94: 1-33.
47. Chattopadhyay K, Saffarian S, Elson EL, Frieden C (2005) Measuring unfolding of proteins in the presence of denaturant using fluorescence correlation spectroscopy. Biophys J 88: 1413-1422. (Pubitemid 40975968)
48. Chattopadhyay K, Elson EL, Frieden C (2005) The kinetics of conformational fluctuations in an unfolded protein measured by fluorescence methods. Proc Natl Acad Sci 102: 2385-2389. (Pubitemid 40279385)
49. Chen H, Rhoades E, Butler JS, Loh SN, Webb WW (2007) Dynamics of equilibrium structural fluctuations of apomyoglobin measured by fluorescence correlation spectroscopy. Proc Natl Acad Sci 104: 10459-10464. (Pubitemid 47185687)
50. Trexler AJ, Rhoades E (2009) α-Synuclein Binds Large Unilamellar Vesicles as an Extended Helix. Biochemistry 48: 2304-2306.
51. Ulmer TS, Bax A, Cole NB, Nussbaum RL (2005) Structure and dynamics of micelle-bound human α-synuclein. J Biol Chem 280: 9595-9603. (Pubitemid 40409655)
52. Sung Y-H, Eliezer D (2007) Residual structure, backbone dynamics, and interactions within the synuclein family. J Mol Biol 372: 689-707.
53. Zimmerman JM, Eliezer N, Simha R (1968) The characterization of amino acid sequences in proteins by statistical methods. J Theoret Biol 21: 170-201.
54. Trexler AJ, Rhoades E (2010) Single molecule characterization of alpha-synuclein in aggregation-prone states. Biophys J 99: 3048-3055.
55. Ahmad B, Chen Y, Lapidus LJ (2012) Aggregation of α-synuclein is kinetically controlled by intramolecular diffusion. Proc Natl Acad Sci 109: 2336-2341.
56. Bodner CR, Maltsev AS, Dobson CM, Bax A (2010) Differential phospholipid binding of α-synuclein variants implicated in Parkinson's disease revealed by solution NMR Spectroscopy. Biochemistry 49: 862-871.
57. Bartels T, Ahlstrom LS, Leftin A, Kamp F, Haass C, et al. (2010) The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding. Biophys J 99: 2116-2124.
58. Mao AH, Crick SL, Vitalis A, Chicoine CL, Pappu RV (2010) Net charge per residue modulates conformational ensembles of intrinsically disordered proteins. Proc Natl Acad Sci 107: 8183-8188.
59. Müller-Späth S, Soranno A, Hirschfeld V, Hofmann H, Rüegger S, et al. (2010) Charge interactions can dominate the dimensions of intrinsically disordered proteins. Proc Natl Acad Sci 107: 14609-14614.
60. O'Brien EP, Morrison G, Brooks BR, Thirumalai D (2009) How accurate are polymer models in the analysis of Forster resonance energy transfer experiments on proteins? J Chem Phys 130: 124903.
61. Wilkins DK, Grimshaw SB, Receveur V, Dobson CM, Jones JA, et al. (1999) Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques. Biochemistry 38: 16424-16431.
62. Morar AS, Olteanu A, Young GB, Pielak GJ (2001) Solvent-induced collapse of α-synuclein and acid-denatured cytochrome c. Prot Sci 10: 2195-2199. (Pubitemid 32988636)
63. Das RK, Pappu RV (2013) Conformations of intrinsically disordered proteins are influenced by linear sequence distributions of oppositely charged residues. Proc Natl Acad Sci.
64. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Molec Biol 157: 105-132.
65. Lee JC, Lai BT, Kozak JJ, Gray HB, Winkler JR (2007) α-Synuclein tertiary contact dynamics. J Phys Chem B 111: 2107-2112.
66. Lapidus LJ, Eaton WA, Hofrichter J (2000) Measuring the rate of intramolecular contact formation in polypeptides. Proc Natl Acad Sci 97: 7220-7225. (Pubitemid 30431444)
67. Lapidus LJ, Steinbach PJ, Eaton WA, Szabo A, Hofrichter J (2002) Effects of chain stiffness on the dynamics of loop formation in polypeptides. Appendix: - Testing a 1-dimensional diffusion model for peptide dynamics. J Phys Chem B 106: 11628-11640. (Pubitemid 35361136)
68. Grupi A, Haas E (2011) Segmental conformational disorder and dynamics in the intrinsically disordered protein α-synuclein and its chain length dependence. J Mol Biol 405: 1267-1283.
69. Chazin WJ, Kordel J, Drakenberg T, Thulin E, Brodin P, et al. (1989) Proline isomerism leads to multiple folded conformations of calbindin D9k: direct evidence from two-dimensional 1H NMR spectroscopy. Proc Natl Acad Sci 86: 2195-2198. (Pubitemid 19102478)
70. Krieger F, Moglich A, Kiefhaber T (2005) Effect of proline and glycine residues on dynamics and barriers of loop formation in polypeptide chains. J Am Chem Soc 127: 3346-3352. (Pubitemid 40365272)
71. Burré J, Sharma M, Südhof TC (2012) Systematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activities. J Neurosci 32: 15227-15242.
72. Bussell R, Ramlall TF, Eliezer D (2005) Helix periodicity, topology, and dynamics of membrane-associated α-Synuclein. Protein Sci 14: 862-872. (Pubitemid 40389356)
73. Giasson BI, Murray IV, Trojanowski JQ, Lee VM (2001) A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem 276: 2380-2386.
74. Yamin G, Munishkina LA, Karymov MA, Lyubchenko YL, Uversky VN, et al. (2005) Forcing nonamyloidogenic β-synuclein to fibrillate. Biochemistry 44: 9096-9107.